Month: March 2024

INCLINE VILLAGE, Nev., March 29, 2024 (GLOBE NEWSWIRE) — Tri Pointe Homes, Inc. (NYSE: TPH) announced today that it will release its financial results for the first quarter of 2024 before the market opens on Thursday, April 25, 2024. The Company will host a conference call on the same day to discuss the results at 7:00 AM Pacific (10:00 AM Eastern). The call will be hosted by Doug Bauer, Chief Executive Officer, Tom Mitchell, Chief Operating Officer, Glenn Keeler, Chief Financial Officer, and Linda Mamet, Executive Vice President and Chief Marketing Officer. Those interested in participating in the call can dial in toll-free at (877) 407-3982, or (201) 493-6780 for international participants. Interested parties can also listen to the call live and view the related slides on the internet under the Events & Presentations heading...

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, March 29, 2024 (GLOBE NEWSWIRE) — Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced the appointment of Dr. Archie Tse as Head of Research & Development, reporting to Mr. Carsten Lu, CEO and Chairman of Adlai Nortye, effective March 29th, 2024. Dr. Tse, M.D. & Ph.D. earned Doctor of Medicine and Doctor of Biochemistry and Molecular Biology degrees from the University of Southern California. Prior to joining Adlai Nortye, Dr. Tse served as the Chief Scientific Officer, Senior Vice President, Head of Research and Early Clinical Development, and Head of CMC at CStone Pharmaceuticals, at which he provided strategic leadership and oversight...

Viactiv® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022 HOUSTON, TEXAS, March 29, 2024 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced its financial results for the year ended December 31, 2023. The Company also provided a corporate update to stockholders. Financial highlights for the year ended December 31, 2023 include the following:Total revenue was $12,248,550 for the year ended December 31, 2023, as compared to $11,049,772...

Management Board of Northern Horizon Capital AS has approved the audited financial results of Baltic Horizon Fund (the Fund) for the year 2023. The financial results remained unchanged compared to the preliminary disclosure on 15 February 2024. Executing our strategy In a challenging economic landscape characterized by inflation, interest rate volatility, and recent geopolitical events, the Fund has assessed various strategic options to navigate these complexities and ensure future growth. Over the past year, our focus has been on reshaping our strategy to foster sustainable value, concentrating efforts on avenues that promise reliable and consistent growth for our investors. In light of prevailing market conditions, we firmly believe that the execution of the ‘Modern City Life’ strategy, introduced to investors in summer 2023, is paramount...

Management Board of Northern Horizon Capital AS has approved the audited financial results of Baltic Horizon Fund (the Fund) for the year 2023. The financial results remained unchanged compared to the preliminary disclosure on 15 February 2024. Executing our strategy In a challenging economic landscape characterized by inflation, interest rate volatility, and recent geopolitical events, the Fund has assessed various strategic options to navigate these complexities and ensure future growth. Over the past year, our focus has been on reshaping our strategy to foster sustainable value, concentrating efforts on avenues that promise reliable and consistent growth for our investors. In light of prevailing market conditions, we firmly believe that the execution of the ‘Modern City Life’ strategy, introduced to investors in summer 2023, is paramount...

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced that it has completed its previously announced repurchase right offer relating to its 1.375% Convertible Senior Notes due 2026 (CUSIP No. 090040AB2) (the “Notes”). The repurchase right offer expired at 5:00 p.m., New York City time, on Thursday, March 28, 2024. Based on information from Deutsche Bank Trust Company Americas as the paying agent for the Notes, US$429,331,000 aggregate principal amount of the Notes were validly surrendered and not withdrawn prior to the expiration of the repurchase right offer. The aggregate cash purchase price of these Notes is US$429,331,000. The Company has accepted all of the surrendered...

Panasonic Holdings Corporation to Maintain Significant Minority Stake in Panasonic Automotive to Accelerate Growth Alongside Apollo Funds Transaction Represents Apollo Funds’ Fourth Private Equity Investment in Japan NEW YORK, March 29, 2024 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that funds managed by Apollo affiliates (the “Apollo Funds”) have entered into a definitive agreement to acquire a majority stake in Panasonic Automotive Systems Corporation (“Panasonic Automotive” or the “Company”), a global leader in advanced automotive solutions, including integrated cockpit systems and in-vehicle electronics, from Panasonic Holdings Corporation (TYO: 6752) (“Panasonic”) in a transaction valued at a total enterprise value of ¥311 billion, subject to certain adjustments at closing. Panasonic will retain a minority stake...